Previously, the country had approved the drug for those under the age of 65. They did this because of insufficient data on its effects on older people. This led to public scepticism about the drug’s effectiveness. It also led to some Germans spurning the drug, leaving many doses unused.
However, on Wednesday, Mrs Merkel said recent studies had now provided enough data to approve it for all ages. Various studies have also shown that the AstraZeneca vaccine is very effective among the elderly.
Belgium also said they will approve the vaccine for older people, following France earlier this week. Currently, only 5% of Germans have so far received a first vaccine shot.
Mrs Merkel said Germany would follow the UK example of stretching the interval between vaccine doses. This will allow them to administer the first dose to a good number of people. The vaccine is given via two injections into the arm. The second dose is administered between four to twelve weeks after the first dose.
The UK started using the AstraZeneca vaccine in December. The health officials in the country said it provides high levels of protection from the virus for all ages. Since then, no one who received the vaccine in trials was admitted to the hospital or became seriously ill with Covid-19.
Check Also;
- UN Says Countries Are Using Covid-19 pandemic As “Pretext” To Gag Opposition
- Vaccine Supply Issues Arise As More People Accept To Take It
- U.S Set To Distribute Covid-19 Vaccines Directly To Pharmacies Across The Country
Please use the button below to contribute to Newslex Point, Inc. using a credit card or via PayPal.